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Abstract  
INTRODUCTION: Acute encephalitis syndrome (AES) is a considerable public health problem.  
AIM: This study was designed to describe the aetiology, demographic features, clinical picture, short-term 
outcome and risk factors of mortality of children with viral encephalitis in Egyptian children. 
METHODS: PCR detection of viruses in the CSF of pediatric patients admitted to the pediatric unit or ICU Cairo 
University Pediatric hospital presenting with encephalitis syndrome. 
RESULTS: Of the 96 patients included in the study, viral etiological agents were detected in 20 cases (20.8%), 
while 76 patients (79.2%) had no definite viral aetiology. The most abundant virus detected was Enterovirus (EV) 
in fourteen (14.5%), two (2.1%) were positive for human herpes simplex virus 6 (HSV-6), one (1.0%), human 
herpes simplex virus1 (HSV-1), one (1.0%) Epstein Barr virus (EBV), one (1.0%), cytomegalovirus (CMV) and one 
(1.0%) with varicella-zoster virus (VZV). On the short term outcome, 22 (22.9) patients died, and 74 (77.1%) 
survived. Severity outcome among survival was vegetative in three cases (4%) severe in 9 (12.16%), moderate in 
14 (18.9%), mild in 29 (39.2%) and full recovery in 19 (25.6%). Mortality risk factors for younger age, the presence 
of apnea, the need for mechanical ventilation and the presence of abnormal CT findings were all significantly 
associated with fatal outcome (p < 0.05). 
CONCLUSION: Enterovirus was the most common cause of encephalitis among Egyptian children. Mortality was 
correlated with younger age and disease severity at admission. Sequelae were high among infected children. 
 
 
 
 
 
 
Introduction 
 
Encephalitis is a critical, potentially lethal 
condition that can cause a variety of viral, bacterial, 
parasitic, as well as from toxins and autoimmune 
reactions to vaccines [1]. 
Although viruses are considered as the most 
important etiological agents of encephalitis worldwide 
[2], viruses are often poorly understood the cause of 
encephalitis. In more than 60% of encephalitis, a 
demonstrable etiologic agent cannot be identified [3] 
[4] [5]. 
Acute viral encephalitis (VE) is an unusual 
presentation of viral infections which affects children 
and young adults mainly after viral invasion of the 
central nervous system presenting by acute onset of 
fever and a change in mental status (including 
symptoms such as confusion, disorientation, coma, or 
inability to talk) and/or new onset of seizures in a 
person of any age at any time of year [2] [6]. 
A range of neurotropic viruses is involved in 
acute viral encephalitis [7]. Moreover Every day new 
viruses are being associated with encephalitis of 
varying severity making specific diagnosis challenging 
[6].  
Herpes Simplex virus (HSV) - 1 is the virus 
most commonly involved in sporadic fatal encephalitis; 
however, other viruses engaged in encephalitis 
include herpesviruses (HSV - 2, varicella-zoster, 
cytomegalovirus, Epstein - Barr, and HHV 6 and 7); 
paramyxoviruses (measles, rubella); 
orthomyxoviruses (influenza A virus); enteroviruses 
(EV 70 and 71, polio -, echo - and coxsackieviruses); 
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flaviviruses (West Nile, Japanese encephalitis, 
dengue and Zika viruses); retroviruses (human 
immunodeficiency virus); alphaviruses (Venezuelan 
equine -, eastern equine -, western equine -
encephalitis); bunyaviruses (La Crosse virus); 
rhabdoviruses (rabies virus); parvovirus (B19); and 
astroviruses [8] [9] [10] [11] [12]. 
In the absence of pathologic evidence of brain 
inﬂammation, diagnosis of encephalitis can be inferred 
from an inﬂammatory response in the CSF or the 
presence of abnormal neuroimaging consistent with 
parenchymal affection and can be used as surrogate 
markers of brain inﬂammation [13].  
The estimated incidence of encephalitis has a 
wide variability and is dependent upon age, 
demographics, climate, the presence of natural host 
for causative agent, and presence of epidemic illness 
[14]. 
Identifying the aetiology of encephalitis is 
challenging. The definition varies, and distinguishing 
encephalitis from meningoencephalitis or even 
meningitis or encephalopathy can be difficult [15]. 
Improving the diagnostic tools for encephalitis 
using PCR rather than tissue cultures has increased 
the yield of etiologies [16] [17].  
Most studies performed to detect viral causes 
of childhood encephalitis are done in western or Asian 
countries, while the literature has a paucity of data in 
the Middle Eastern region [1] [9] [12]. 
This study was done to acknowledge the 
etiological viral causes of childhood encephalitis in 
Egypt and to demonstrate the clinical features, 
seasonal variations and short-term outcome of the 
cases. 
 
 
Methodology 
 
This two - year prospective cohort study 
conducted on children diagnosed with encephalopathy 
syndrome selected from those admitted to the 
pediatric unit or pediatric ICU Cairo University 
Pediatric hospital during a search period all over the 
whole year. 
 
Ethical consideration  
The study was designed to conform to the 
requirements of the latest revision of Helsinki 
Declaration of Bioethics [18]. The researcher obtained 
the approval of the medical ethical committee of the 
National Research Centre and the ethical committee 
of Research Committee of Pediatrics Department-
Faculty of Medicine - Cairo University. Signed 
informed consents were collected from the legal 
guardian of the children before enrolment and after 
explanation of the aim and nature of the study. 
 
Inclusion criteria  
All pediatric patients from the age of 1 month 
to 13 years presented by encephalopathy syndrome 
were included in the study.  
Acute encephalopathy was defined using The 
Consensus Statement of the International Encephalitis 
Consortium; Encephalitis was defined as acute 
encephalopathy fever with alteration of consciousness 
and/or with neurological deficit, secondary to central 
nervous system involvement lasting more than 24 
hours, and not more than a one-week history [13]. 
 
Exclusion criteria 
Other causes of encephalopathy as a brain 
tumour, vascular disorders, intoxication, or psychosis, 
traumatic brain injury, pre-existing neurological 
conditions as metabolic encephalopathy or epilepsy, 
febrile seizure. 
Bacterial meningitis was excluded by the 
clinical picture of the patient with severe irritability and 
signs of meningeal irritation with positive CSF 
bacterial cultures, other infectious etiologies as brain 
abscess, acute organ dysfunction detected from 
clinical examination and lab finding. 
 
Data collection  
Demographic data as age, sex and season 
were included. Clinical data as full history and 
neurological manifestations were recorded. The place 
of admission whether hospital ward or intensive care 
settings or the need for mechanical ventilation was 
mentioned. 
In addition to the routine lab investigations, 
CSF cell count, chemistry and culture were also done. 
Pleocytosis was defined with CSF cells >15 cells/mm
3
 
for infants aged 1 to 2 months, and >5 cells/mm3 for 
patients aged >2 months; lymphocytes predominance 
if > 60%, high CSF proteins if > 45 mg/dL, CSF 
glucose: serum ratio should be 60%. 
Urgent non - contrast CT imaging of the brain 
was done whenever indicated, not all patients were 
followed by MRI due to the extreme difficulty in 
transferring patients to the radiology unit especially if 
clinically unstable or if the patient was on mechanical 
ventilation. However resonant magnetic imaging (MRI) 
was scheduled upon discharge to the ward. 
Patients were managed symptomatically until 
a definite cause could be found. All patients received 
acyclovir on admission and continued for 14-21 days 
when diagnosed with herpes virus or stopped if 
diagnosed otherwise, and received the appropriate 
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treatment; discussing treatment is beyond the scope 
of our research.  
The clinical course of the patient is followed 
for a short term during his hospital stay, and case 
lethality was recorded whether he survived or 
discharged. 
The neurological outcome of the survived 
patients was classified according to pediatric cerebral 
overall category scale into, no squeal, mild, moderate, 
severe, vegetative and brain dead [19]. 
 
Laboratory investigations 
Nucleic acid extraction, reverse transcription 
and PCR amplification 
RNA extraction was done automatically using 
QIAamp MinElute Virus Spin Kit (QIAGEN) Cat. No 
(57704), on QIA cube machine. cDNA was 
synthesised by reverse transcription using 
RevertAidTM First Strand cDNA Synthesis kit Cat.No. 
(K1622 SG1300)(Fermentas, Ontario, Canada), 
accords to manufacturer’s instruction. cDNA was 
stored at -80°C until processed. 
In PCR, efficiency can be reduced by 
inhibitors that may be present in the clinical specimen 
An Internal Control (Meningitis ACE IC) is supplied. 
This allows the user both to control the nucleic acid 
isolation procedure and to check for possible PCR 
inhibition. The Internal Control is introduced into each 
specimen before nucleic acid extraction and is co-
amplified with target nucleic acid from the clinical 
specimen. Also; the 8 - methoxypsoralen (8 -MOP) 
system is used to extinguish the template activity of 
contaminated DNAs. 8 - MOP is known to intercalate 
into double-stranded nucleic acids and form a 
covalent interstrand crosslink after photoactivation 
with incident light of a wavelength of 320 - 400 nm. 
The Seeplex Meningitis - V2, employs a “Dual Priming 
Oligonucleotide (DPOTM) technology, which provides 
freedom in primer design and PCR optimisation and 
maximises PCR specificity and sensitivity. Briefly, 
PCR amplification was performed using 5 μL of cDNA, 
2 μL of 10X MV2 primer mixture, 3 μL of 8 - MOP and 
10 μL of 2X Multiplex Master Mix (Seegene Inc.) in a 
total volume of 20 μL. The 2X Multiplex Master Mix 
contains dNTP and enzyme for the specific 
amplification of the pathogen's genome and 10X ACE 
PM is the primer mixture for the specific target 
amplification. The amplification protocol was as 
follows: initial denaturation at 94°C for 15 min, 40 
cycles of denaturation at 94°C for 30 sec, annealing at 
63°C for 90 sec, extension at 72°C for 90 sec, and 
final annealing at 72°C for 10 minutes. The amplified 
PCR products were electrophoresed in 2% agarose 
gels and stained with ethidium bromide.  
 
 
Statistical method 
Data were coded and entered using the 
statistical package SPSS (Statistical Package for the 
Social Sciences) version 23. Data were summarised 
using mean, standard deviation, median, minimum 
and maximum in quantitative data and using 
frequency (count) and relative frequency (percentage) 
for categorical data. Comparisons between 
quantitative variables were made using the non-
parametric Mann-Whitney test [20]. For comparing 
categorical data, Chi-square (2) test was performed. 
The exact test was used instead when the expected 
frequency is less than 5 [21]. P - value less than 0.05 
was considered as statistically significant.  
 
 
Results 
 
The study was conducted from first January 
2015 to 31th of December 2016. One hundred twenty 
children admitted with criteria encephalopathy 
syndrome were enrolled in the study in either general 
pediatric units or intensive care units. Twenty four 
patients were excluded from investigation (as 
revealed other reasons for presentation, e.g. systemic 
lupus encephalitis, acute disseminated 
encephalomyelitis, brain abscess, or vasculopathy. 
Ninety-six patients were eligible for the study, 
60 (62.55%) were males, and 36 (37.5%) were 
females, 50 (52%) needed intensive care admission, 
while 43 (44.8%) needed mechanical ventilation.  
Table 1: Demographic and clinical finding of studied cases 
Age (months) 
 Mean ± SD 29.34 ± 28.29 
 Range 1-120 
The length of hospital stays (days) 
 Mean ± SD 15.42 ± 15.53 
 Range 2 -107  
 Frequency  Percent 
Gender  
 Female  36 37.5% 
 Male 60 62.55% 
Seasonal variation    
 Summer 37 38.5% 
 winter 30 31.2% 
 Spring 16 16.7% 
 Autumn  13  13.5% 
Clinical data 
Coma  77 (80%) 
Fever 68 (70%) 
Seizures  64 (66%) 
increased intracranial pressure 14 (14%) 
irritability 13 (13%) 
focal deficits 7 (7%) 
Intensive care admission 50 52% 
Mechanical ventilation need  43 44.8% 
CT imaging finding  
Normal 67 69.8% 
Brain Edema 23 24.0% 
Hypodense areas of hypoxia. 6 6.25% 
Severity outcome among survival*  
vegetative  3 4% 
severe 9 12.1% 
moderate 14 18.9% 
mild 29 39.2% 
Full recovery 19 25.6% 
Mortality rates n  
Death 22 22.9 
Survived  74 77.1 
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The age of patients ranged from 1 month-12 
years (mean 29.34 + 28.29). The majority of patients 
presented during summer (37 or 38.5%), and winter 
(30 or 31.2%), while minority presented during spring 
(16 or 16.7%) and autumn (13 or 13.5%).   
Clinical manifestations of the studied patients 
included: coma or disturbed conscious level in 77 
(80%) patients, fever in 68 (70%) patients, seizures in 
64 (66%) patients, increased intracranial pressure 14 
(14%) patients, irritability in 13 (13%) patients and 
focal deficits in 7 (7%) patients.  
The length of hospital stay was 2 -107 days 
(15.42 + 15.53). CT imaging finding was normal in 67 
(69.8%) of cases, while twenty -three (24.0%) 
revealed brain oedema. Six cases (6.25%) showed 
hypodense areas of hypoxia. On the short - term 
outcome 22 (22.9%) patients died, and 74 (77.1%) 
survived (Table 1). 
CSF pleocytosis ranged from 0 - 300 (46 + 
59), lymphocytes predominated in 76 (79.2%), and 
polymorphnuclear cells in 19 (19.8%), CSF was 
acellular in one case that was neutropenic and 
acquired CMV infection. CSF glucose level ranged 
from 10 - 127 mg/dL (62.12 + 24.06) and CFS 
proteins 5 - 305 gm/dL (47.7 + 46.43) 
Viral etiological agents were detected in 20 
cases (20.8%), while 76 patients (79.2%) had no 
definite viral etiology. The most abundant virus 
detected was EV in fourteen (14.5%), two (2.1%) were 
positive for HSV - 6, one (1.0%) HSV - 1, one (1.0%) 
EBV, one (1.0 %)CMV and one (1.0%) with VZV 
(Table 2). 
Table 2: Laboratory and CSF finding of studied cases 
CSF finding Frequency Percent 
Lymphocytes predominance 76 79.2% 
Polymorphonuclear cells predominance 19 12.1% 
Acellular 1 1% 
CSF glucose level mg/dl 
 Mean ± SD 62.12 ± 24.06 
 Range 10-127 
CFS proteins level gm/dl  
 
 Mean ± SD 47.7 ± 46.43 
 Range 5-305 
Viral etiological agents  Frequency Percent 
Ev 14 14.5% 
Hsv - 6 2 2.1% 
Hsv - 1 1 1% 
EBV 1 1% 
Cmv 1 1% 
Vzv 1 1% 
No virus detected 76 79.2% 
 
Severity outcome among survival according to 
pediatric cerebral performance category scale were 
vegetative in three cases (4%) severe in 9 (12.16%), 
moderate in 14 (18.9%), mild in 29 (39.2%) and full 
recovery in 19 (25.6%). 
Table 3 demonstrate clinical picture according 
to the causative virus; there was no significant 
difference between clinical presentation, CSF finding 
or outcome.  
 
Table 3: Demographic, clinical of studied cases according to 
the causative virus 
 EV 
(n = 14) 
HSV-1 
(n =1) 
HSV-6 (n = 2) EBV 
(n =1) 
CMV 
(n =1) 
VZV 
(n =1) 
No virus 
(n = 76) 
Demographic data 
Age  
(median in 
months)  
 
19 
 
 
24 
 
24 
 
14 
 
67 
 
48 
 
18 
 
Sex,  
(n, percentage) 
male  
female  
 
 
10 (10.4%) 
4 (4.1%) 
 
 
1(1%) 
 
 
2 (2%) 
 
 
1 (1%) 
 
 
 
1 (1%) 
 
 
 
1(1%) 
 
 
46 (48%) 
30 (31%) 
Season  
Summer 
Winter 
Spring 
Autumn  
 
4 (4.1%) 
3 (3.1%) 
4 (4.1%) 
3 (3.1%) 
 
1(1%) 
 
 
2 (2%) 
 
 
 
 
1(1%) 
 
 
 
 
1(1%) 
 
 
 
 
1(1%) 
 
Clinical data 
Coma  
n (percentage) 
12 (12.5%) 1(1%) 2 (2%) 1 (1%) 1 (1%) 1 (1%) 62 (64.5%) 
Irritability 
n (percentage) 
1 (1%) 0 1 (1%) 1 (1%) 0 0 10(10.4%) 
Increased ICP 
n (percentage) 
2 (2%) 0 0 0 0 0 12 (12.5%) 
Motor  
n (percentage) 
2 (2%) 0 0 0 0 0 6 (6.25%) 
MV 5 (5.2) 0 2 (2%) 1 (1%) 1 (1%) 1 (1%) 32 (33.3%) 
Mortality  
n (percentage) 
5 (5.2%) 0 0 0 1 0 16 (16.6%) 
Neurological 
deficits  
0 
Mild 
Moderate 
Severe 
vegetative 
 
3 (3.1%) 
2 (2%) 
2 (2%) 
1 (1%) 
1 (1%) 
 
 
1 (1%) 
 
 
 
1 (1%) 
 
1 (1%) 
 
 
1 (1%) 
  
 
 
 
1 (1%) 
 
16 (16.6%) 
24 (14.58) 
11 (11.45%) 
8 (8.3%) 
1 (1%) 
EV: enterovirus; HSV: herpes simplex virus, EBVEpstein Barr virus, CMV cytomegalovirus; 
VZV: varicella zoster virus; CSF: cerebrospinal fluid, ICPintracranial pressure, MV: 
mechanical ventilation. 
 
Mortality risk factors assessment 
demonstrated that the younger age, the presence of 
apnea, the need for mechanical ventilation and the 
presence of abnormal CT finding as brain oedema 
and hypodense areas were all significantly associated 
with fatal outcome (p < 0.05) Table 4. 
Five cases among EV group died making 
mortality within the group 35.7%. Another CMV case 
died, this case was brain dead on admission. 
Table 4: Risk Factors for mortality 
 the  
Age   0.027* 
Sex   0.380 
Pleocytosis   0.099 
Coma   0.108 
Fever   0.762 
Seizures   0.647 
Apnea   0.001 
Motor deficit  1 
Mechanical ventilation   < 0.001* 
Edema of CT  0.004* 
Virus Type   0.392 
* (p < 0.05) is considered significant 
 
 
Discussion 
 
 Viral encephalitis is a significant cause of 
childhood morbidity and mortality. Up to 60% of cases 
of suspected viral encephalitis remain unexplained 
due to the failure of routine laboratory techniques to 
detect an infectious agent [22].  
In our study, the incidence of confirmed cases 
of viral encephalitis was 20.6%. Although this 
percentage is lower than our studies to some extent 
[15] [23], but it is similar to many other studies [12] 
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[13] [24] Moreover with studies with large time scale 
and larger sample size as the prospective study held 
by California Encephalitis Project (CEP) all over 7 
years and included 1570 cases of encephalitis which 
revealed only 16% of encephalitis cases had a 
confirmed or probable etiology [25]. 
Accurate diagnosis and immediate 
management of viral encephalitis are critical to 
reducing complications and fatality rates [26] A 
diagnostic gap is still present although the progress 
that had taken place with both traditional and 
molecular biological technologies in detecting the 
causes of viral encephalitis. 
The current study aimed to acknowledge the 
etiological viral causes of childhood encephalitis in 
Egypt and to demonstrate the clinical features, 
seasonal variations and short-term outcome of the 
cases. 
Many studies set in Western industrialised 
countries tend to focus on HSV, VZV, EBV, EV, 
respiratory viruses or bacterial encephalitis [25] [27]. 
In contrast, Asian countries are faced with a high 
incidence of arboviruses as Dengue virus and 
Japanese encephalitis virus [28] [29] [30]. 
As few data was found on viral encephalitis in 
developing countries and there was no clear 
published data on viral encephalitis in Egyptian 
children. Fourteen cases were caused by EV 
infections; which was the most abundant virus in the 
study; there was no specific temporal relation to any 
season of the year.  
Two (2.1%) were positive for HSV - 6, one 
(1.0%) HSV - 1, one (1.0%) EBV, one (1.0%) CMV 
and one (1.0%) with VZV. This change of encephalitic 
viral epidemiology is related to the widespread of 
vaccination, making HSV-1 dethroned as the most 
common cause of viral encephalitis among children. 
Incidence of EV ranged from less than one, to 25% in 
previous studies [25] [28] [31] [32] [33]. 
The study addressed the clinical profile and 
short-term complication of the viral encephalitis. There 
was male preponderance in our study (62.55%); this 
was in keeping with most studies [32] [34]. Reasons 
for higher male incidence could be due to more 
exposure to the causative agents or the underlying 
genetic makeup of a male. Clinical manifestations 
among different etiologies were mostly imperceptible, 
except for rabies patient who developed 
laryngospasm and hydrophobia after exposure to a 
dog bite. As previously mentioned in other studies, in 
the current study coma was the most common 
presentation [35] [36]. 
CSF pleocytosis is suggestive of an 
inflammatory process of the brain, the lack of CSF 
pleocytosis, however, does not exclude encephalitis. It 
is recognised that the CSF may be devoid of cells in 
immunocompromised patients [37] or early during 
infection [38]. 
Forty-five percent to 55% of children with viral 
encephalitis will show a CSF lymphocytic pleocytosis, 
although within the first 48 hours this may be 
neutrophil-predominant [39]. 
Case fatality in our study was 22.9%, and this 
was significantly associated with younger age, the 
presence of apnea, the need for mechanical 
ventilation and was highly significant with the 
presence of abnormal CT finding. All of these risk 
factors indicate disease severity.  
In general the overall case fatality of viral 
encephalitis is between 0% and 29% [27] [32] [40] 
[41]. 
Mechanical ventilation was a risk factor of 
fatality in Mailles and his colleagues in France, 2007 
[23]. While younger age and low Glasgow Coma 
Score (GCS) were risk factors [28]. 
Immunocompromise was a major mortality factor in 
the study population in England [42]. Patients with 
normal neuroimaging studies were more likely to 
recover than patients with abnormal neuroimaging (P 
= 0.008.) The risk of death or severe damage in 
patients less than 1 year of age was 5.0 - fold (p < 
0.001) greater than that of older children [43]. Among 
survivals, there were neurological sequelae in 
74.32%, in the present study. That was higher than 
other studies which reported sequelae in 25 – 69% 
[35] [36]. 
The limitations of our study were a high 
proportion of unknown causes, which may be due to a 
later presentation of cases beyond the detection 
timeframe of PCR, the elimination of other extra - CSF 
sites for molecular sampling, the presence of a viral 
cause that is deficient in our labs diagnostic assays, 
the presence of non - infectious cause of encephalitis 
as autoimmune encephalitis, or the presence of a new 
virus. Owing to the high prevalence of EV in the study 
group, it is recommended to include PCR for EV in the 
routine workup of encephalitis. 
In summary, enterovirus was the most 
common cause of encephalitis among Egyptian 
children. There was a high percentage of unknown 
cases. Mortality was correlated with younger age and 
disease severity at admission. Sequelae were high 
among infected children.  
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